triamcinolone + sodium hyaluronate

This drug is a combination therapy consisting of the synthetic glucocorticoid **triamcinolone** (likely triamcinolone acetonide) and the viscosupplement **sodium hyaluronate** (marketed under the brand name **Hyruan**). It is administered via intra-articular injection for the treatment of knee osteoarthritis. Triamcinolone acts as a potent anti-inflammatory agent by binding to glucocorticoid receptors, thereby reducing joint pain and swelling. Sodium hyaluronate, a high-molecular-weight polysaccharide, provides lubrication and shock absorption within the joint, mimicking the properties of natural synovial fluid. This combination is designed to provide both rapid anti-inflammatory relief and sustained mechanical support to the osteoarthritic knee. The specific combination protocol has been investigated in clinical trials led by **Taipei Medical University**.

Brand names

Hyruan

Other names

Triamcinolone plus hyruantriamcinolone acetonide + sodium hyaluronate